Crsp analysts
WebMay 10, 2024 · The analysts also say that they have little conviction in upcoming data. CRSP continues enrollment in the Phase I CARBON study, which recently expanded to a pivotal trial with additional data ... Web45 minutes ago · Analyst’s Disclosure: I/we have a beneficial long position in the shares of CRSP either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my ...
Crsp analysts
Did you know?
WebCRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations. WebMar 23, 2024 · CRISPR Therapeutics reported a net loss per share of $1.41 in fourth-quarter 2024, narrower than the Zacks Consensus Estimate of a loss of $2.32. The company had posted a loss of $1.84 per share ...
WebApr 14, 2024 · Crispr Therapeutics AG (CRSP) stock is trading at $50.43 as of 10:23 AM on Friday, Apr 14, a loss of -$0.13, or -0.26% from the previous closing price of $50.56. … WebApr 13, 2024 · Investment analysts at Cantor Fitzgerald started coverage on shares of CRISPR Therapeutics (NASDAQ:CRSP - Get Rating) in a research note issued to investors on Thursday, The Fly reports. The brokerage set an "overweight" rating and a $72.00 price target on the stock. Cantor Fitzgerald's price target suggests a potential upside of …
WebMar 17, 2024 · Gene-editing leader CRISPR Therapeutics (CRSP 0.33%) has generated sizzling returns for investors over the last 12 months. But one analyst thinks the biotech stock can go much higher. WebBased on analysts offering 12 month price targets for CRSP in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .
WebAnalysts Offer Insights on Healthcare Companies: Cano Health (CANO), Crispr Therapeutics AG (CRSP) and AngioDynamics (ANGO) Apr. 3, 2024 at 12:30 p.m. ET on TipRanks.com
WebApr 14, 2024 · CRISPR Therapeutics AG CRSP shares soared 16.3% in the last trading session to close at $50.56. The move was backed by solid volume with far more shares changing hands than in a normal session ... cloud computing rootsWeb21 hours ago · While CRSP managed to steal the show on the Street today, the SCD therapeutic announcement presents tailwinds for other gene-editing stocks. Notably, … byu football gamecastWebApr 12, 2024 · CRISPR Therapeutics AG (CRSP) closed the last trading session at $45.41, gaining 0.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ... cloud computing sandeep bhowmik pdfbyu football fieldWeb1 day ago · Although CRSP has traded at a recent price of $43.47/share, the average analyst target is 100.69% higher at $87.24/share. Similarly, VCYT has 44.87% upside … cloud computing salary in usaWebApr 3, 2024 · CRISPR Therapeutics (Nasdaq:CRSP) earnings and revenue forecasts, price targets, future return on equity. Compare CRISPR Therapeutics AG's growth forecast against it's industry peers. ... CRSP - Analysts future estimates and past financials data (USD Millions) Date Revenue Earnings Free Cash Flow Cash from Op Avg. No. … byu football gWeb20 hours ago · CRSP has an average price target of $84.19 among all 26 analysts with coverage of the stock. That implies an upside of about 68%. That implies an upside of … cloud computing sample programs